Harnessing strain-release driven reactivity of a chiral SuFEx reagent: Stereocontrolled access to sulfinamides, sulfonimidamides, and sulfoximines

Justin Lopchuk,Paresh Athawale,Zachary Shultz,Alexandra Saputo,Yvonne Hall
DOI: https://doi.org/10.26434/chemrxiv-2024-m92kq
2024-03-29
Abstract:Efforts aimed at enriching the chemical and structural diversity of small molecules have invigorated synthetic exploration in the last two decades. Spatially defined molecular functionality serves as the foundation to construct unique chemical space to further advance discovery science. The chiral SuFEx reagent t-BuSF provides a modular platform for the stereocontrolled bifunctionalization of sulfur. Here we report a third functional feature of t-BuSF enabled by carbamoyl torsional strain-release that further expands the S(IV) and S(VI) chemical space accessible as showcased in over seventy examples, multiple applications in medicinal chemistry, organocatalysis, and diversity-oriented synthesis. The methods presented herein allow for rapid asymmetric diversification around a stereodefined sulfur center with readily available building blocks, improving upon the current state-of-the-art for sulfinyl and sulfonimidoyl synthesis.
Chemistry
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: **How to develop an efficient, modular and stereocontrolled method for the synthesis of S(IV) and S(VI) functionalized derivatives of sulfur - containing compounds (especially sulfinamides, sulfonimides and sulfoximines)**. ### Specific problem description: 1. **Limitations of current synthetic methods**: - Existing methods lack stereocontrol over the sulfur center. - The synthesis steps are cumbersome and inefficient. - The use of isocyanates as raw materials limits subsequent sulfur functionalization. - It is difficult to achieve chiral separation and diverse construction. 2. **Importance of target compounds**: - S(IV) and S(VI) functionalized compounds have wide applications in medicinal chemistry, organocatalysis and diversity - oriented synthesis. - For example, sulfonimide urea compounds are used as NLRP3 inhibitors (immunomodulators) and show potential in the development of anticancer drugs. 3. **Unmet needs**: - A practical and modular method is required to achieve stereocontrol at the sulfur center using diverse and readily available starting materials. - The problem of the instability of the S(IV) stereocenter in traditional methods needs to be overcome. ### Core solutions of the paper: The paper proposes a new strategy based on the chiral SuFEx reagent **t - BuSF**, and by introducing a third functional feature (i.e., carbonyl torsional strain release), the following goals are achieved: - Rapid and asymmetric diversification around a well - defined sulfur stereocenter. - A method for rapidly generating more than 70 examples of S(IV) and S(VI) compounds from readily available starting materials is provided. - It shows wide applications in medicinal chemistry, organocatalysis and diversity - oriented synthesis. ### Key points of the solution: 1. **Versatility of the chiral SuFEx reagent t - BuSF**: - By taking advantage of its trifunctionalization, it can fully combine with carbon and nitrogen nucleophiles. - High - level stereocontrol over the sulfur center is achieved. 2. **New reaction modes**: - A new mechanism of action of the N,N - diisopropylurea group in t - BuSF is introduced, enabling it to participate in the reaction as an "activating group". - Through a simple amine - exchange reaction, sulfinamide (7) and sulfonimide (8) are respectively generated, providing two independent pathways to rapidly diversify the S(IV) and S(VI) core structures. 3. **Overcoming traditional limitations**: - The disadvantage of the instability of the S(IV) stereocenter in traditional methods is avoided. - A one - step method for directly converting tert - butylsulfoximine to sulfonimide urea is provided. ### Summary: The paper aims to address the deficiencies of existing synthetic methods in terms of efficiency, modularity and stereocontrol. By developing a chiral SuFEx reagent platform based on t - BuSF, a more efficient and flexible synthetic route for the functionalization of sulfur - containing compounds is provided. This method not only expands the accessible S(IV) and S(VI) chemical space, but also provides new tools for drug research and development and the field of organocatalysis.